Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e16d1b3130c75f905199bb431589879 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-18 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14532 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14865 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09D5-1681 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-1451 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09D5-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-1486 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-145 |
filingDate |
2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f943856de41dce4f3daf6c8f5e115cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7aa28360de17618b89056f05fbf39569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_627896c4a89c1ae9f63df1347bd9321e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5693deb68f8510e4ec060c329f8ae233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c867ece2bf1076199d53d782cb4b917c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9220997f03d993d1101c4b7a7e2dc2ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1859d4ffcf65da7030fd16a8db2ad39 |
publicationDate |
2019-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2019147578-A1 |
titleOfInvention |
Implantable polymer surfaces exhibiting reduced in vivo inflammatory responses |
abstract |
Embodiments of the invention provide optimized polymeric surfaces adapted for use with implantable medical devices as well as methods for making and using such polymeric surfaces. These polymer surfaces have a constellation of features that function to inhibit or avoid an inflammatory immune response generated by implantable medical devices. Typical embodiments of the invention include an implantable glucose sensor used in the management of diabetes having a polymer surface with the disclosed constellation of features. |
priorityDate |
2018-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |